3-(4-Methoxybenzyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione

Catalog No. :
ACSCBF964
CAS No. :
1313712-12-7
Molecular Formula :
C15H16N2O3
Molecular Weight :
272.30

IUPAC Name:3-(4-methoxybenzyl)-1,5,6,7-tetrahydro-2H-cyclopenta[d]pyrimidine-2,4(3H)-dione

3-(4-Methoxybenzyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$207.00Login to see priceInquiryInquiry
1g95%$519.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-Methoxybenzyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione
IUPAC Name3-(4-methoxybenzyl)-1,5,6,7-tetrahydro-2H-cyclopenta[d]pyrimidine-2,4(3H)-dione
MDL No.MFCD18910609
Molecular FormulaC15H16N2O3
Molecular Weight272.30
SMILESO=C1NC2=C(CCC2)C(N1CC3=CC=C(OC)C=C3)=O
InChI KeyYDDKJGXQBWJDFL-UHFFFAOYSA-N
Synonym3-(4-Methoxy-benzyl)-1,5,6,7-tetrahydro-cyclopentapyriMidine-2,4-dione;3-(4-Methoxybenzyl)-6,7-dihydro-1H-cyclopenta[d]pyriMidine-2,4(3H,5H)-dione;3-[(4-methoxyphenyl)methyl]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidine-2,4-dione;1H-Cyclopentapyrimidine-2,4(3H,5H)-dione, 6,7-dihydro-3-[(4-methoxyphenyl)methyl]-
CAS No.1313712-12-7

Synthetic Route by SureRoute

1. ACSCBF964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSGKH251 route compound structure diagram
    ACSGKH2515466-00-2 In Stock
  4. Then
  5. ACSCBF964 route product structure diagram
    ACSCBF9641313712-12-7
Inquiry

2. ACSCBF964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSGKH251 route compound structure diagram
    ACSGKH2515466-00-2 In Stock
  4. Then
  5. ACSCBF964 route product structure diagram
    ACSCBF9641313712-12-7
Inquiry

Comments (0)